MOBILion Launches MOBIE HRIM for Biotherapeutic Drug Development

Designed to address characterization challenges during biopharmaceutical drug development and quality monitoring.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MOBILion Systems Inc. has launched its first commercial High-Resolution Ion Mobility (HRIM) product, MOBIE, designed to address characterization challenges during biopharmaceutical drug development and quality monitoring. MOBIE is designed to provide fast, efficient separations with superior resolution and reproducibility, faster, simpler method development, and greater instrument uptime, according to the company. This new technology aims to help accelerate and simplify the workflows of challeng...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters